Muñoz Mariela, Vilos Cristian, Cantín Mario
School of Medical Technology, Faculty of Health Sciences, Universidad Santo Tomás Temuco, Chile ; Fellow Researcher, Universidad Científica del Sur Lima, Perú
Center for Integrative Medicine and Innovative Science (CIMIS), Universidad Andres Bello Facultad de Medicina, Santiago, Chile ; Center for the Development of Nanoscience and Nanotechnology CEDENNA FB0807 Santiago, Chile.
Int J Clin Exp Med. 2015 Jul 15;8(7):11225-9. eCollection 2015.
Thrombophilias is a recognized risk factor for thrombotic events. The prothrombin variant G20210A gene mutation has been commonly examined using polymerase chain reaction (PCR). Currently, in many clinical laboratories, performing the PCR in real-time technique, which, in addition to identifying the G20210A mutation, makes possible the detection of other mutations in the 3'UTR of the prothrombin gene by melting curve analysis, due to the ability of this analysis to be amplicon-dependent (e.g., C20209T, C20221T and A20218G). We report the first case in Chile that describes the atypical prothrombin C20209T mutation, in a 50-year-old male patient diagnosed with deep vein thrombosis in the lower limb and family history of thrombophilia. In the literature, there are few studies of the prevalence and functionality of this mutation; its association with thrombotic events is controversial.
血栓形成倾向是血栓事件公认的危险因素。凝血酶原变异体G20210A基因突变通常采用聚合酶链反应(PCR)检测。目前,在许多临床实验室中,采用实时PCR技术,除了能鉴定G20210A突变外,由于熔解曲线分析能够依赖扩增子(例如C20209T、C20221T和A20218G),还能检测凝血酶原基因3'非翻译区的其他突变。我们报告了智利首例描述非典型凝血酶原C20209T突变的病例,该病例为一名50岁男性患者,被诊断为下肢深静脉血栓形成且有血栓形成倾向家族史。在文献中,关于该突变的患病率和功能的研究很少;其与血栓事件的关联存在争议。